Although the mechanism by which BTApep-TAT inhibited cancer progression was not determined clearly because the function of BORIS was not thoroughly investigated, the specificity of the BTApep-TAT interaction with BORIS may suggest that the formation of PROTACs induced BORIS degradation. Here, CTCFL is linked to cancer.